Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: Health Challenges in Chronic Inflammation Initiative - (Full Appl)

University of Calgary

$2,292,479.00

Brain Dysfunction in Chronic Inflammatory Disease: Reciprocal Effects of CNS and Periphery Crosstalk

FY 2013-14

Summary
Chronic inflammatory diseases, such as rheumatoid arthritis, hepatitis and inflammatory bowel disease share many common features. Among the most significant of these are changes in the brain that lead to behavioral symptoms of fatigue, depression, cognitive dysfunction and social withdrawal. Such debilitating symptoms markedly diminish the quality of life of hundreds of thousands of Canadians living with these conditions. One might think, of course a patient with inflammatory bowel disease, liver disease, or rheumatoid arthritis will be depressed, anxious and distracted; who wouldn't be? We contend that these behavioral changes are not a response to disease. Rather, a fundamental alteration occurs in the way in which the brain functions in the face of a chronic inflammatory disease. Despite the impact of these symptoms, the mechanisms of brain dysfunction in chronic inflammation are not well understood. Furthermore, there is an increasing appreciation that altered central nervous system function has considerable consequences for disease progression; this too has not been explored. We wish to address these shortcomings by understanding how persistent inflammation may cause disturbances in the brain and how chronic immune-mediated inflammatory diseases reprogram the brain to alter neuronal function, precipitating co-morbid behavioral dysfunction, which influences the disease processes. To effectively examine these important problems we have assembled a trans-disciplinary team of experts in the management of chronic inflammatory disease: neuroscientists, psychiatrists and imaging experts who are fluent in understanding brain-body communication and plasticity of brain function. Our unique basic-clinical-translational research team is poised to facilitate the discovery of common central mechanisms underlying the neurological and psychological conditions associated with chronic inflammation. Translating our discoveries to improve patient outcomes is our ultimate goal.
Program
Team Grant: Health Challenges in Chronic Inflammation Initiative - (Full Appl)
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
296425
Name
Swain Mark G
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Arthritis Society; Crohn's and Colitis Canada (Toronto, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Health Challenges in Chronic Inflammation Initiative - (Full Application)
Projecttitle
Brain Dysfunction in Chronic Inflammatory Disease: Reciprocal Effects of CNS and Periphery Crosstalk
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$2,292,479
Cihrequipment2
$0
Programname2
Team Grant: Health Challenges in Chronic Inflammation Initiative - (Full Appl)
Keyworddelim
Chronic Inflammation; Illness Behavior; Immune-Mediated Diseases; Inflammation; Inflammatory Bowel Disease; Liver Disease; Neurocognition; Neuroimaging; Quality Of Life; Rheumatoid Arthritis
Abstract
Chronic inflammatory diseases, such as rheumatoid arthritis, hepatitis and inflammatory bowel disease share many common features. Among the most significant of these are changes in the brain that lead to behavioral symptoms of fatigue, depression, cognitive dysfunction and social withdrawal. Such debilitating symptoms markedly diminish the quality of life of hundreds of thousands of Canadians living with these conditions. One might think, of course a patient with inflammatory bowel disease, liver disease, or rheumatoid arthritis will be depressed, anxious and distracted; who wouldn't be? We contend that these behavioral changes are not a response to disease. Rather, a fundamental alteration occurs in the way in which the brain functions in the face of a chronic inflammatory disease. Despite the impact of these symptoms, the mechanisms of brain dysfunction in chronic inflammation are not well understood. Furthermore, there is an increasing appreciation that altered central nervous system function has considerable consequences for disease progression; this too has not been explored. We wish to address these shortcomings by understanding how persistent inflammation may cause disturbances in the brain and how chronic immune-mediated inflammatory diseases reprogram the brain to alter neuronal function, precipitating co-morbid behavioral dysfunction, which influences the disease processes. To effectively examine these important problems we have assembled a trans-disciplinary team of experts in the management of chronic inflammatory disease: neuroscientists, psychiatrists and imaging experts who are fluent in understanding brain-body communication and plasticity of brain function. Our unique basic-clinical-translational research team is poised to facilitate the discovery of common central mechanisms underlying the neurological and psychological conditions associated with chronic inflammation. Translating our discoveries to improve patient outcomes is our ultimate goal.
Competitiondate
201310
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Swain, Mark G
Approvedterm
5 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $971,869~ $0~Inst of Nutr Metabolism &Diab~ $70,610~ $0~Institute of Aging~ $1,250,000~ $0~